Moderna Shares Drop to Five-Year Low After Slashing Revenue, …

2 days ago · By Connor Hart Moderna's stock plummeted to an almost five-year low after the biotech company cut its revenue outlook for this year and said that sales for last year will come …

17%
OFF

Watch These Moderna Price Levels As Stock Plummets After …

2 weeks from now

1 day ago · Moderna shares will likely remain under scrutiny after plunging nearly 17% Monday as the embattled drug maker slashed its 2025 revenue forecast by $1 billion. Watch these crucial …

investopedia.com

$1
OFF

Moderna's $1 Billion Revenue Forecast Cut Sends Stock

2 weeks from now

2 days ago · Moderna shares tumbled Monday after the company cut its 2025 revenue forecast by $1 billion. The company expects much of its revenue to be realized in the back half of the year …

investopedia.com

22%
OFF

Moderna Stock Plummets After $1 Billion Cut To 2025 Sales Forecast

2 weeks from now

2 days ago · Moderna (MRNA) shares plummeted $9.29, or 22%, to $22.96 in early trading after the company slashed its 2025 sales forecast, sparking investor concerns. The revised …

wallstreetpit.com

20%
OFF

Moderna Shares Tumble On Slashed Sales Guidance - BioPharma Dive

2 weeks from now

2 days ago · Shares in Moderna dropped by more than 20% Monday morning after the biotechnology company slashed its revenue guidance for 2025 by $1 billion. Moderna now …

biopharmadive.com

21%
OFF

Why Moderna Stock Just Crashed 21% - The Motley Fool

2 weeks from now

2 days ago · The coronavirus vaccine maker's shares plunged 21.2% through 10:20 a.m. ET Monday after it updated investors on its 2024 performance and released new guidance for 2025.

fool.com

17%
OFF

Moderna Stock Poised For Another Drop After Shaving Nearly $1 …

2 weeks from now

2 days ago · Drug maker Moderna 's stock plunged more than 17% in pre-market trading on Monday after the company slashed its sales outlook by $1 billion.

ibtimes.com

$1
OFF

Moderna Lowers 2025 Sales Forecast By $1 Billion - CNBC

2 weeks from now

Mar 26, 2024 · Moderna now expects 2025 revenue to come in between $1.5 billion and $2.5 billion, most of which will come in the second half of the year.

cnbc.com

16%
OFF

Moderna Stock Plummets 16% After £819.59M Guidance Cut Over …

2 weeks from now

1 day ago · Moderna is expediting its cost-cutting program and rolling back R&D amid a drop in vaccination rates and low revenues from a new vaccine.

ibtimes.co.uk

20%
OFF

Moderna Stock Dips 20%: Reasons Behind The Decline | Invezz

2 weeks from now

2 days ago · Why did Moderna lower sales guidance today? Moderna saw a sharp decline in its COVID market share (US retail) from 48% to 40% only in 2024 – and the company expects a …

invezz.com

21%
OFF

Moderna’s Stock Slides 21% After Company Lowers Full-year Sales ...

2 weeks from now

Aug 1, 2024 · Moderna Inc.’s stock tumbled 21% Thursday, after the biotech company cut its sales guidance for 2024, offsetting a narrower-than-expected second-quarter loss and revenue …

marketwatch.com

20%
OFF

Moderna’s CEO Sees An ‘Evolution Of Strategy.’ The Stock ... - MSN

2 weeks from now

Coming into Thursday, Moderna shares have fallen 20% this year. In early August, the company slashed its 2024 revenue guidance by as much as 25%, citing low Covid-19 vaccine sales in …

msn.com

20%
OFF

Who's To Blame As Moderna's Stock Falls Amid Slashed Guidance?

2 weeks from now

Aug 1, 2024 · Moderna (MRNA) shares slid more than 20% Thursday after the company slashed its sales guidance for 2024, largely because of a lack of new COVID-19 vaccine orders from …

yahoo.com

94%
OFF

Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?

2 weeks from now

1 day ago · Moderna shares will likely remain under scrutiny after plunging nearly 17% Monday as the embattled drug maker slashed its 2025 revenue forecast by $1 billion. Watch these crucial …

yahoo.com

17%
OFF

Moderna Stock Poised For Another Drop After Shaving Nearly $1 …

2 weeks from now

1 day ago · Drug maker Moderna 's stock plunged more than 17% in pre-market trading on Monday after the company slashed its sales outlook by $1 billion. The company reported …

moneytimes.com

17%
OFF

Moderna Crashes 17%. 'No Inflection In Sight' After Guidance

2 weeks from now

1 day ago · Moderna stock crashed Monday after the firm slashed its outlooks for 2024 and 2025, and announced an expanded cost-cutting initiative.

yahoo.com

16%
OFF

Moderna Stock Plummets 16% After £819.59M Guidance Cut… - Inkl

2 weeks from now

1 day ago · Moderna is expediting its cost-cutting program and rolling back R&D amid a drop in vaccination rates and low revenues from a new vaccine.

inkl.com

20%
OFF

Moderna Stock Plunges Nearly 20% As Company Reports Poor …

2 weeks from now

Sep 12, 2024 · Moderna (NYSE: MRNA) stock plunged Thursday on news it will be slashing its research and development (R&D) budget by about 20% over the next three years, a result of …

yahoo.com

20%
OFF

Moderna Stock Plummets On Cost-Cutting Measures

2 weeks from now

Sep 12, 2024 · Shares of Moderna Inc (NASDAQ:MRNA) are plummeting today, after the biotech giant announced it was slashing its research budget by about 20%. The company also teased …

schaeffersresearch.com

FAQs about Moderna Shares Drop to Five-Year Low After Slashing Revenue, … Coupon?

Why did Moderna stock drop 2024?

Moderna (MRNA) shares slid more than 20% Thursday after the company slashed its sales guidance for 2024, largely because of a lack of new COVID-19 vaccine orders from the European Union. The company said it now expects total sales between $3 billion and $3.5 billion for the year. That's down from the $4 billion forecast in the first quarter. ...

Why did Moderna stock fall 22%?

By Connor Hart Moderna's stock plummeted to an almost five-year low after the biotech company cut its revenue outlook for this year and said that sales for last year will come in at the lower end of its guidance. Shares fell 22% to $33.07 in late morning trading Monday. ...

Why are Moderna shares down 20% this year?

Moderna shares are down 20% this year. In early August, the company slashed its 2024 revenue guidance by as much as 25%, citing low Covid-19 vaccine sales in Europe and tight competition in the U.S. The guidance cut raised questions about Moderna’s 2026 break-even target and spurred concerns the company could run out of cash. ...

Will Moderna lose money in 4 years?

Analysts think Moderna will lose money for at least four years. Moderna 's (MRNA -20.49%) sales are slowing down, and Moderna stock is going down -- a lot. The coronavirus vaccine maker's shares plunged 21.2% through 10:20 a.m. ET Monday after it updated investors on its 2024 performance and released new guidance for 2025. ...

Will Moderna cut costs in 2026?

The company also said it was speeding up and expanding a cost-cutting plan. It expects to cut cash costs by $1 billion in the new year, with additional cuts planned in 2026. Moderna pulled in most of its revenue last year from its COVID-19 vaccine, Spikevax, which brought in more than $3 billion in sales. ...

Is Moderna a good stock to buy in 2025?

Moderna expects to realize a bigger chunk of the estimated sales in the back half of 2025. Majority of its revenue will be attributed to its Covid shot and the respiratory syncytial virus vaccine it has launched fairly recently, as per a press release on Monday. Moderna stock is now down close to 30% versus its year-to-date high. ...